Capital Fund Management (CFM)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8M Sell
704,500
-486,800
-41% -$13M 0.09% 313
2025
Q4
$29.7M Sell
1,191,300
-2,770,700
-70% -$69.9M 0.08% 328
2025
Q3
$101M Sell
3,962,000
-184,300
-4% -$4.55M 0.26% 58
2025
Q2
$101M Buy
4,146,300
+481,500
+13% +$11.2M 0.28% 60
2025
Q1
$92.9M Sell
3,664,800
-261,000
-7% -$6.83M 0.27% 77
2024
Q4
$104M Buy
3,925,800
+987,500
+34% +$26.8M 0.27% 81
2024
Q3
$85M Sell
2,938,300
-71,500
-2% -$2.09M 0.23% 105
2024
Q2
$84.2M Sell
3,009,800
-878,900
-23% -$24.2M 0.25% 101
2024
Q1
$108M Sell
3,888,700
-2,012,000
-34% -$55.8M 0.31% 55
2023
Q4
$170M Buy
5,900,700
+1,963,700
+50% +$59.4M 0.46% 21
2023
Q3
$131M Buy
3,937,000
+1,196,300
+44% +$42.3M 0.45% 30
2023
Q2
$101M Sell
2,740,700
-255,600
-9% -$9.95M 0.41% 34
2023
Q1
$122M Buy
2,996,300
+2,158,400
+258% +$93.2M 0.58% 17
2022
Q4
$42.9M Sell
837,900
-648,500
-44% -$31.1M 0.29% 77
2022
Q3
$65M Buy
1,486,400
+478,000
+47% +$23.2M 0.51% 28
2022
Q2
$52.9M Sell
1,008,400
-926,200
-48% -$47.2M 0.48% 29
2022
Q1
$100M Buy
1,934,600
+118,400
+7% +$6.14M 0.82% 3
2021
Q4
$107M Buy
1,816,200
+781,000
+75% +$38.7M 0.77% 6
2021
Q3
$44.5M Buy
+1,035,200
New +$45.9M 0.33% 56
2021
Q1
Sell
-15,400
Closed -$567K 1543
2020
Q4
$567K Sell
15,400
-33,084
-68% -$1.21M 0.01% 1110
2020
Q3
$1.69M Sell
48,484
-19,604
-29% -$687K 0.02% 691
2020
Q2
$2.11M Sell
68,088
-1,147,174
-94% -$39M 0.03% 478
2020
Q1
$37.6M Sell
1,215,262
-373,221
-23% -$12.7M 0.58% 22
2019
Q4
$59M Buy
1,588,483
+273,723
+21% +$9.75M 0.46% 35
2019
Q3
$44.8M Buy
1,314,760
+932,263
+244% +$33.9M 0.4% 48
2019
Q2
$15.7M Sell
382,497
-182,025
-32% -$7.23M 0.14% 207
2019
Q1
$22.7M Sell
564,522
-712,821
-56% -$28.5M 0.2% 139
2018
Q4
$52.9M Buy
1,277,343
+170,538
+15% +$7.08M 0.47% 29
2018
Q3
$46.3M Buy
1,106,805
+1,028,493
+1,313% +$39.6M 0.25% 77
2018
Q2
$2.7M Sell
78,312
-9,802
-11% -$335K 0.01% 966
2018
Q1
$2.97M Sell
88,114
-264,554
-75% -$9.09M 0.02% 862
2017
Q4
$12.1M Buy
352,668
+282,155
+400% +$9.62M 0.07% 353
2017
Q3
$2.39M Buy
70,513
+30,988
+78% +$996K 0.02% 726
2017
Q2
$1.26M Sell
39,525
-716,825
-95% -$22.6M 0.01% 844
2017
Q1
$24.5M Sell
756,350
-854,689
-53% -$26.9M 0.2% 137
2016
Q4
$49.6M Buy
1,611,039
+959,351
+147% +$29.3M 0.43% 41
2016
Q3
$20.9M Sell
651,688
-907,178
-58% -$30.3M 0.19% 136
2016
Q2
$52.1M Buy
1,558,866
+1,463,795
+1,540% +$46.7M 0.49% 41
2016
Q1
$2.67M Sell
95,071
-297,860
-76% -$8.51M 0.03% 619
2015
Q4
$12M Sell
392,931
-94,755
-19% -$2.98M 0.12% 228
2015
Q3
$14.5M Sell
487,686
-198,995
-29% -$6.38M 0.16% 158
2015
Q2
$21.8M Sell
686,681
-826,125
-55% -$26.9M 0.28% 87
2015
Q1
$49.9M Buy
1,512,806
+1,432,491
+1,784% +$45.5M 0.68% 16
2014
Q4
$2.37M Sell
80,315
-270,140
-77% -$7.75M 0.03% 646
2014
Q3
$9.83M Buy
350,455
+297,860
+566% +$8.36M 0.11% 225
2014
Q2
$1.48M Sell
52,595
-78,312
-60% -$2.23M 0.02% 828
2014
Q1
$3.99M Sell
130,907
-26,139
-17% -$779K 0.05% 447
2013
Q4
$4.56M Sell
157,046
-277,940
-64% -$8.09M 0.06% 418
2013
Q3
$11.8M Sell
434,986
-673,927
-61% -$18.3M 0.16% 154
2013
Q2
$29.5M Buy
+1,108,913
New +$30.6M 0.45% 18

Other funds holding PFE

Capital Fund Management (CFM)'s PFE Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Pfizer (PFE) in Q1 2026: 264,357 shares worth $7.42M. The stake represents 0.03% of the portfolio and ranks #694 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in PFE as recently as Q3 2025.

Capital Fund Management (CFM) first reported a position in PFE in Q4 2013 and has held it in 35 quarters since. The position peaked at $58.5M in Q2 2014. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Capital Fund Management (CFM) held 264,357 shares of Pfizer worth $7.42M as of Q1 2026.
  • Pfizer was a new Capital Fund Management (CFM) position in Q1 2026.
  • Pfizer made up 0.03% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #694 holding.
  • Capital Fund Management (CFM) first reported a position in Pfizer in Q4 2013 and has held it in 35 quarters since.
  • Capital Fund Management (CFM)'s Pfizer position peaked at $58.5M in Q2 2014.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.